This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NDUFS2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NDUFS2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~52.5 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Acetylated + Methylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The A05618-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | lysates from A431, Hela cell line, mouse brain and rat brain tissue lysate (from left to right), (catalog A05618-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A05618-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | goat anti-rabbit IgG, 1:10000 (catalog A05618-1) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
NDUFS2 has a predicted mass of 52.5 kDa; annotated isoforms could affect migration, but no distinct bands or empirical migration are demonstrated.
| Band near 52.5 kDa | consistent with the predicted NDUFS2 mass; confirm band identity |
| Several bands at different positions | isoforms 1 and 2 are possible contributors; their migration is unknown |
| Band away from 52.5 kDa | an alternative isoform is possible, but its size is not supplied |
| Little or no band in whole-cell lysate | NDUFS2 detection may depend on recovery of mitochondrial inner membrane protein |
| UniProt predicted mass | provides a 52.5 kDa reference, not a measured band position |
| Alternative splicing | could change apparent size, but no migration difference is supplied |
| Isoform 1 | its individual mass and migration are not supplied |
| Isoform 2 | its individual mass and migration are not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | mitochondrial inner membrane protein may be poorly recovered | check mitochondrial enrichment and lysate preparation |
| Band lower than expected | isoform identity or sample degradation is unresolved | compare samples and verify identity with a second antibody |
| Multiple bands | isoforms 1 and 2 are annotated, but their band positions are unknown | check specificity with NDUFS2 knockdown or knockout |
| Weak or no signal | insufficient recovery of mitochondrial protein is possible | check loading and mitochondrial recovery |
| Fragments below expected size | sample degradation is possible; fragment masses are not supplied | repeat with fresh, protease-protected lysate and verify specificity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | High | Protein (IHC) | HPA → |
| Colon | glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Cervix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for NDUFS2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
All three listed anti-NDUFS2 antibodies have Western blot images. A05618-1 was tested on human cell lines and mouse and rat brain lysates; A05618-3 and M05618-1 were tested on named human, mouse, and rat samples. The latter two report bands below the expected 53 kDa.
Which to pick: Match the antibody to your sample: A05618-1 includes brain lysates; A05618-3 includes brain and lung lysates across the named species; M05618-1 includes lung lysates and additional cell lines. All three have WB images. Check the reported band position when choosing A05618-3 or M05618-1.